Literature DB >> 12740799

A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics.

Paul J Thuluvath1, Hwan Y Yoo, Richard E Thompson.   

Abstract

Reliable models that could predict outcome of liver transplantation (LT) may guide physicians to advise their patients of immediate and late survival chances and may help them to optimize organ use. The objective of this study was to develop user-friendly models to predict short and long-term mortality after LT in adults based on pre-LT recipient characteristics. The United Network for Organ Sharing (UNOS) transplant registry (n = 38,876) from 1987 to 2001 was used to develop and validate the model. Two thirds of patients were randomized to develop the model (the modeling group), and the remaining third was randomized to cross-validate (the cross-validation group) it. Three separate models, using multivariate logistic regression analysis, were created and validated to predict survival at 1 month, 1 year, and 5 years. Using the total severity scores of patients in the modeling group, a predictive model then was created, and the predicted probability of death as a function of total score then was compared in the cross-validation group. The independent variables that were found to be very significant for 1 month and 1 year survival were age, body mass index (BMI), UNOS status 1, etiology, serum bilirubin (for 1 month and 1 year only), creatinine, and race (only for 5 years). The actual deaths in the cross-validation group followed very closely the predicted survival graph. The chi-squared goodness-of-fit test confirmed that the model could predict mortality reliably at 1 month, 1 year, and 5 years. We have developed and validated user-friendly models that could reliably predict short-term and long-term survival after LT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740799     DOI: 10.1053/jlts.2003.50089

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  15 in total

1.  Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.

Authors:  Jennifer E Layden; Scott J Cotler; Shellee A Grim; Michael J Fischer; Michael R Lucey; Nina M Clark
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

2.  Using Bayesian networks to predict survival of liver transplant patients.

Authors:  Nathan Hoot; Dominik Aronsky
Journal:  AMIA Annu Symp Proc       Date:  2005

3.  Evaluation of liver transplant recipients.

Authors:  Paul J Thuluvath
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

4.  Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation.

Authors:  Robert J Wong; Ramsey Cheung; Ryan B Perumpail; Edward W Holt; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2015-01-18       Impact factor: 3.199

Review 5.  [Long-term results after liver transplantation].

Authors:  H Schrem; N Till; T Becker; H Bektas; M P Manns; C P Strassburg; J Klempnauer
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

6.  Physician predictions of graft survival following liver transplantation.

Authors:  Nathan R Hoot; Irene D Feurer; Mary T Austin; Michael K Porayko; J Kelly Wright; Nancy M Lorenzi; C Wright Pinson; Dominik Aronsky
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

7.  Liver transplantation for acute hepatic failure.

Authors:  Eric T Castaldo; Ravi S Chari
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

8.  Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.

Authors:  Masatoshi Ishigami; Takashi Honda; Akihiko Okumura; Tetsuya Ishikawa; Makoto Kobayashi; Yoshiaki Katano; Yasuhiro Fujimoto; Tetsuya Kiuchi; Hidemi Goto
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

9.  Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma.

Authors:  Abhishek Mathur; Edson S Franco; John P Leone; Hussein Osman-Mohamed; Haydy Rojas; Nyingi Kemmer; Guy W Neff; Alexander S Rosemurgy; Angel E Alsina
Journal:  HPB (Oxford)       Date:  2012-11-19       Impact factor: 3.647

10.  Intragastric balloon as a novel modality for weight loss in patients with cirrhosis and morbid obesity awaiting liver transplantation.

Authors:  Narendra Singh Choudhary; Rajesh Puri; Neeraj Saraf; Sanjiv Saigal; Naveen Kumar; Rahul Rai; Amit Rastogi; Sanjay Goja; Prashant Bhangui; Sumana K Ramchandra; Vikram Raut; Randhir Sud; Arvinder Soin
Journal:  Indian J Gastroenterol       Date:  2016-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.